A 340B health check helps healthcare organizations identify compliance gaps before they become larger operational problems. By reviewing eligibility records, purchasing data, patient records, inventory, and contract pharmacy activity, covered entities can spot errors early and take corrective action before an audit or internal review exposes them.
The 340B Drug Pricing Program allows eligible healthcare organizations to purchase certain outpatient drugs at discounted prices. Managing the program requires accurate records, clear procedures, and regular monitoring. Even organizations with established processes can develop gaps as staff, systems, and pharmacy arrangements change.
A structured health check gives covered entities a practical way to review their operations, understand their risks, and maintain stronger compliance.
What Is a 340B Health Check?
A 340B health check is a structured review of an organization's 340B program to determine whether its processes, records, and controls support program requirements.
It examines how the organization manages eligibility, drug purchases, patient eligibility, inventory, contract pharmacies, and required documentation. The goal is to identify weaknesses early and address them before they lead to compliance issues.
A 340B health check may include:
- Reviewing covered entity registration and eligibility.
- Checking purchasing and dispensing records.
- Validating patient eligibility and covered services.
- Reviewing contract pharmacy arrangements.
- Checking inventory and replenishment processes.
- Examining duplicate discount prevention controls.
- Assessing documentation and audit readiness.
The scope should reflect the organization's size, program structure, and specific risks. A hospital with several outpatient locations may need a different review from a smaller clinic with one contract pharmacy.
Why Finding Compliance Gaps Early Matters
Small errors can become difficult to resolve when they remain unnoticed across multiple locations, systems, or reporting periods.
For example, a data mapping error between a pharmacy system and a 340B platform may cause transactions to be classified incorrectly. If the issue continues for months, the organization may need to review a large volume of records to determine the extent of the problem.
Early reviews help organizations:
- Reduce compliance risks: Identify process weaknesses before they spread.
- Improve data accuracy: Find mismatched records and incomplete transaction details.
- Strengthen audit preparation: Keep supporting documents organized and accessible.
- Protect program integrity: Check whether purchasing and dispensing processes follow applicable requirements.
- Improve accountability: Give staff clear responsibilities for resolving identified issues.
A health check does not guarantee compliance or prevent every audit finding. It provides an opportunity to identify problems, assess their impact, and document corrective action.
Where Should Organizations Look for Compliance Gaps?
A useful 340B compliance assessment focuses on the areas where errors are most likely to affect program integrity.
1. Covered Entity Eligibility and Registration
Start by confirming that the organization remains eligible for the program and that its registration details are accurate.
Review the registered sites, associated outpatient facilities, and any other information relevant to the organization's eligibility category. Changes in ownership, locations, services, or organizational structure should trigger a review of whether registration updates are required.
Common warning signs include outdated registration information, unclear responsibility for maintaining records, and differences between registered locations and actual operations.
Organizations should compare their records with current HRSA requirements and applicable program guidance rather than relying on old internal documents.
2. Patient Eligibility and Covered Services
The 340B program has specific requirements concerning eligible patients and the relationship between covered entities and the care provided. Organizations should make sure their policies explain how patient eligibility is determined and documented.
Review a sample of transactions and check whether the supporting records demonstrate that applicable requirements were met.
Potential warning signs include incomplete patient records, unclear links between services and medication use, inconsistent eligibility decisions, and policies that do not match actual workflows.
A health check should also examine whether staff understand how patient eligibility rules apply to different care settings.
3. Purchasing and Inventory Management
Purchasing and inventory controls help ensure that discounted drugs are managed appropriately and that records support the organization's use of the program.
Compare purchasing records, inventory movements, dispensing information, and replenishment records where applicable. Investigate unexplained differences instead of assuming they are routine system errors.
For example, a pharmacy may report dispensing activity that does not reconcile with the organization's expected replenishment records. The difference could reflect timing, incomplete data, or a process failure. The organization should investigate and document the reason.
A reliable review should cover both the accuracy of the data and the procedures staff follow when discrepancies appear.
4. Duplicate Discount Prevention
Covered entities must have controls to prevent prohibited duplicate discounts involving 340B drugs and Medicaid rebates.
Review how the organization identifies Medicaid claims, determines the relevant billing arrangements, and coordinates information across its pharmacy, billing, and 340B systems.
Warning signs may include unclear policies for Medicaid billing, outdated payer information, inconsistent claim classifications, or limited communication between departments.
The correct approach depends on the covered entity's arrangements and applicable requirements. Organizations should confirm their processes against current HRSA guidance and relevant state Medicaid requirements.
5. Contract Pharmacy Compliance
Contract pharmacy arrangements introduce additional data and coordination requirements. Covered entities should review the agreements, transaction records, oversight procedures, and responsibilities associated with each arrangement.
Check whether contract pharmacy records can be reconciled with the covered entity's 340B records and whether exceptions are investigated promptly.
Common risks include missing transaction details, inconsistent reporting, unclear responsibilities, and unresolved discrepancies between systems.
Regular reviews should also confirm that contract pharmacy arrangements and related records remain consistent with current program requirements.
How to Conduct a Practical 340B Health Check
A repeatable review process makes it easier to find issues, assign responsibility, and track improvements.
Step 1: Define the Scope
Identify which facilities, systems, pharmacies, and processes the review will cover. Include areas that have changed recently, such as new locations, pharmacy arrangements, software updates, or staffing changes.
Set a clear review period and document the reason for selecting each area.
Step 2: Gather the Right Records
Collect relevant registration details, policies, purchase records, dispensing data, inventory information, billing records, contract pharmacy reports, and prior audit findings.
Make sure the review team can trace transactions across systems where necessary. Missing or inconsistent source data should be treated as a finding rather than ignored.
Step 3: Validate the Data
340B data validation helps confirm that records are complete, consistent, and suitable for review.
Compare relevant records across systems and investigate missing fields, duplicate transactions, inconsistent identifiers, and unexplained differences. Use documented rules so the same checks can be repeated.
Automated reports can help identify unusual patterns, but staff should review the underlying records before deciding whether a discrepancy represents a compliance problem.
Step 4: Assess and Prioritize Risks
Not every finding carries the same level of risk. Rank issues according to their potential impact, the number of transactions affected, how long the problem may have existed, and whether a required control is missing.
For example, a minor documentation issue may require a different response from a recurring problem involving patient eligibility or duplicate discount prevention.
Document the evidence behind each finding and the reason for its priority.
Step 5: Assign Corrective Actions
Each finding should have an owner, a deadline, and a clear resolution plan.
Corrective action may involve updating a procedure, fixing a system configuration, retraining staff, correcting records, or conducting a broader review of affected transactions.
When a potential violation is identified, the organization should follow applicable reporting and corrective-action requirements. Seek qualified compliance or legal guidance when the issue requires interpretation.
Step 6: Verify the Fix
Closing a finding should require evidence that the correction worked. Repeat the relevant test, review new transactions, or examine updated records to confirm that the problem has not continued.
Keep the original finding, investigation notes, corrective action, and verification results together. This creates a clear record of how the organization responded.
Best Practices for Ongoing 340B Program Monitoring
A one-time assessment can identify current problems, but regular monitoring helps prevent them from returning.
Consider these practices:
- Set a review schedule: Use risk-based checks throughout the year, with additional reviews after significant operational changes.
- Maintain written procedures: Keep policies current and make sure staff can follow them in practice.
- Use consistent data checks: Apply repeatable validation rules to relevant purchasing, dispensing, and billing records.
- Coordinate across departments: Involve pharmacy, finance, billing, IT, and compliance teams where their responsibilities overlap.
- Track recurring findings: Look for patterns that suggest a deeper process or system problem.
- Prepare for audits continuously: Keep records organized rather than waiting for an audit notice.
- Review external guidance: Monitor relevant HRSA requirements and other applicable rules when making changes to program operations.
Organizations that need help reviewing their processes can explore healthcare compliance and program support resources as part of their broader approach to 340B oversight.
Common Questions About 340B Health Checks
How often should a 340B health check be performed?
There is no single schedule that fits every organization. A risk-based schedule should reflect the organization's size, transaction volume, contract pharmacy arrangements, previous findings, and operational changes. Additional checks may be appropriate when new systems or processes are introduced.
Is a 340B health check the same as a formal audit?
No. A health check is generally an internal or advisory review used to identify risks and improve controls. A formal audit may have a defined scope, methodology, and reporting requirements. A health check can support audit preparation, but it does not replace any required audit or official review.
What are common 340B compliance gaps?
Common areas to investigate include outdated registration information, insufficient patient eligibility documentation, purchasing and inventory discrepancies, weak duplicate discount controls, contract pharmacy data issues, and incomplete records of corrective actions.
What should an organization do after finding a compliance gap?
Document the issue, assess its potential impact, identify affected transactions or processes, and assign corrective action to a responsible person. Verify that the fix works and follow applicable reporting or remediation requirements.
Conclusion
A 340B health check gives healthcare organizations a practical way to find compliance gaps before they become more difficult to investigate and resolve. By reviewing eligibility, patient records, purchasing, inventory, billing controls, and contract pharmacy activity, organizations can identify weaknesses and make informed improvements.
The strongest approach combines accurate data, clear procedures, regular monitoring, and documented corrective action. When these practices become part of routine operations, covered entities are better prepared to protect program integrity and respond to compliance concerns.
Sign in to leave a comment.